ARCHIVES

A Biostatistics Paper Alleges Potential Harm To Patients In Two Duke Clinical Studies

This article is from The Cancer Letter archive.

Vol. 35 No. 36 | October 2, 2009

Download PDF Visit The Full Archive

Related Articles

Safety Concerns About Saltz Regimen Were Statistical Artifact, ODAC Finds.

December 14, 2001

NCI To Fund More Than 1,000 Competing Grants Under FY 1992 Budget

November 22, 1991

Breast Cancer Vs. Other Cancers In Budget Showdown

July 3, 1992

House Committee Investigates Marketing Practices Of Amgen And J&J For ESAs.

April 4, 2008

Pres. Bill Clinton to Serve as Honorary Chair Of NBCC’s Breast Cancer Deadline 2020

November 16, 2012

VeriStrat Biomarker Test Predicts Treatment Outcomes In Phase III NSCLC Trial

May 30, 2014